Home » CADENCE COMPLETES ACQUISITION OF INTRAVENOUS ACETAMINOPHEN RIGHTS
CADENCE COMPLETES ACQUISITION OF INTRAVENOUS ACETAMINOPHEN RIGHTS
Cadence Pharmaceuticals Inc. announced Thursday that it has completed its acquisition of the rights to an intravenous formulation of acetaminophen, IV APAP.
San Diego Source (http://www.sddt.com/News/article.cfm?SourceCode=20060330tqc)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May